Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2006

1.

Olanzapine with ondansetron and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in lung cancer.

Wang W, Lou G, Zhang Y.

Medicine (Baltimore). 2018 Sep;97(37):e12331. doi: 10.1097/MD.0000000000012331.

2.

Children with cyclic vomiting syndrome: phenotypes, disease burden and mitochondrial DNA analysis.

Ye Z, Xue A, Huang Y, Wu Q.

BMC Gastroenterol. 2018 Jul 3;18(1):104. doi: 10.1186/s12876-018-0836-5.

3.

Schnuppern an einem mit Isopropylalkohol getränkten Tupfer hilft bei Übelkeit.

Steurer J.

Praxis (Bern 1994). 2018 Jul;107(14):788-789. doi: 10.1024/1661-8157/a002994. German. No abstract available.

PMID:
29969966
4.

Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies.

Ammar HO, Mohamed MI, Tadros MI, Fouly AA.

AAPS PharmSciTech. 2018 Jul;19(5):2276-2287. doi: 10.1208/s12249-018-1019-y. Epub 2018 May 29.

PMID:
29845503
5.

The Neurobiology of Opioid Addiction and the Potential for Prevention Strategies.

Peltz G, Südhof TC.

JAMA. 2018 May 22;319(20):2071-2072. doi: 10.1001/jama.2018.3394. No abstract available.

PMID:
29710202
6.

Cutaneous refractile foreign body microemboli with intravascular injection of oral medication.

Bercovici N, Russomanno K, Santoro F, Scola C, Murphy M, Elaba Z.

J Cutan Pathol. 2018 May;45(5):365-368. doi: 10.1111/cup.13125. Epub 2018 Mar 14.

PMID:
29430677
7.

A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.

Foo WC, Khong YM, Gokhale R, Chan SY.

Int J Pharm. 2018 Mar 25;539(1-2):165-174. doi: 10.1016/j.ijpharm.2018.01.047. Epub 2018 Feb 27.

PMID:
29414124
8.

A Comparison of Fosaprepitant and Ondansetron for Preventing Postoperative Nausea and Vomiting in Moderate to High Risk Patients: A Retrospective Database Analysis.

Murakami C, Kakuta N, Kume K, Sakai Y, Kasai A, Oyama T, Tanaka K, Tsutsumi YM.

Biomed Res Int. 2017;2017:5703528. doi: 10.1155/2017/5703528. Epub 2017 Dec 19.

9.

Enhanced transdermal delivery of ondansetron using nanovesicular systems: Fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example.

Habib BA, Sayed S, Elsayed GM.

Eur J Pharm Sci. 2018 Mar 30;115:352-361. doi: 10.1016/j.ejps.2018.01.044. Epub 2018 Jan 31.

PMID:
29407555
10.

Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy.

Kosinski TM, Brown MC, Zavala PJ.

Int J Pharm Compd. 2018 Jan-Feb;22(1):41-46.

PMID:
29385385
11.

Effect of a single dose of i.v. ondansetron on QTc interval in emergency department patients.

Li K, Vo K, Lee BK, Addo N, Coralic Z.

Am J Health Syst Pharm. 2018 Mar 1;75(5):276-282. doi: 10.2146/ajhp161070. Epub 2018 Jan 9.

PMID:
29317399
12.

Ondansetron does not prevent physical dependence in patients taking opioid medications chronically for pain control.

Chu LF, Rico T, Cornell E, Obasi H, Encisco EM, Vertelney H, Gamble JG, Crawford CW, Sun J, Clemenson A, Erlendson MJ, Okada R, Carroll I, Clark JD.

Drug Alcohol Depend. 2018 Feb 1;183:176-183. doi: 10.1016/j.drugalcdep.2017.06.043. Epub 2017 Aug 14.

PMID:
29278818
13.

Torsades de Pointes after Ondansetron Infusion in 2 Patients.

Lee DY, Trinh T, Roy SK.

Tex Heart Inst J. 2017 Oct 1;44(5):366-369. doi: 10.14503/THIJ-16-6040. eCollection 2017 Oct.

14.

White-Lipped Tree Viper (Cryptelytrops albolabris) Envenomation in an American Viper Keeper.

Greene S, Galdamez LA, Tomasheski R.

J Emerg Med. 2017 Dec;53(6):e115-e118. doi: 10.1016/j.jemermed.2017.09.003. Epub 2017 Nov 6.

PMID:
29102099
15.

Perioperative Gabapentin Improves Patient-Centered Outcomes After Inguinal Hernia Repair.

Quail J, Spence D, Hannon M.

Mil Med. 2017 Nov;182(11):e2052-e2055. doi: 10.7205/MILMED-D-17-00107.

PMID:
29087880
16.

Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial.

Hagbom M, Novak D, Ekström M, Khalid Y, Andersson M, Lindh M, Nordgren J, Svensson L.

PLoS One. 2017 Oct 27;12(10):e0186824. doi: 10.1371/journal.pone.0186824. eCollection 2017.

17.

Use of Prophylactic Ondansetron with Intravenous Opioids in Emergency Department Patients: A Prospective Observational Pilot Study.

Culver MA, Richards EC, Jarrell DH, Edwards CJ.

J Emerg Med. 2017 Nov;53(5):629-634. doi: 10.1016/j.jemermed.2017.06.040. Epub 2017 Oct 5.

PMID:
28987314
18.

Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis.

Yokoi A, Mihara T, Ka K, Goto T.

PLoS One. 2017 Oct 4;12(10):e0186006. doi: 10.1371/journal.pone.0186006. eCollection 2017. Review.

19.

Clinical Practice: Nausea and vomiting in acute gastroenteritis: physiopathology and management.

Canziani BC, Uestuener P, Fossali EF, Lava SAG, Bianchetti MG, Agostoni C, Milani GP.

Eur J Pediatr. 2018 Jan;177(1):1-5. doi: 10.1007/s00431-017-3006-9. Epub 2017 Sep 30. Review.

PMID:
28963679
20.

Palonosetron is nonsuperior to ondansetron in acute phase but provides superior antiemetic control in delayed phase for pediatric patients administered highly emetogenic chemotherapy.

Tan J, Wang S, Liang X, Li CC, Zhang J, Zhao Z, Kong XR, Deng X, Peng L, Yang C.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26815. Epub 2017 Sep 22.

PMID:
28941006

Supplemental Content

Loading ...
Support Center